However, current DPP-4 inhibitors have been linked to adverse effects such as gastrointestinal issues, severe joint pain, nasopharyngitis, hypersensitivity, and nausea (Huang et al., 2020). This evidence concerns the gene DPP4 and nasopharyngitis.